[미국특허]
Compositions and methods for nutrition supplementation
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-031/714
A61K-009/00
A61K-031/015
A61K-031/355
A61K-031/375
A61K-031/4415
A61K-031/455
A61K-031/51
A61K-031/519
A61K-031/525
A61K-031/593
A61K-033/06
A61K-033/08
A61K-033/26
A61K-033/30
A61K-045/06
A61K-031/07
A61K-031/4406
A61K-031/715
A61K-047/34
출원번호
US-0478774
(2017-04-04)
등록번호
US-10201560
(2019-02-12)
발명자
/ 주소
Giordano, John A.
Balzer, Charles J.
출원인 / 주소
Exeltis USA, Inc.
대리인 / 주소
Sheppard Mullin Richter & Hampton LLP
인용정보
피인용 횟수 :
0인용 특허 :
99
초록▼
The present invention relates to compositions that may be swallowable, chewable or dissolvable, comprising various vitamins and minerals, and in a specific embodiment comprising vitamin A, beta carotene, B-complex vitamins, vitamin C, vitamin D3, vitamin E, iron, magnesium and zinc, and methods for
The present invention relates to compositions that may be swallowable, chewable or dissolvable, comprising various vitamins and minerals, and in a specific embodiment comprising vitamin A, beta carotene, B-complex vitamins, vitamin C, vitamin D3, vitamin E, iron, magnesium and zinc, and methods for using these compositions for nutritional supplementation in subjects undergoing physiologically stressful events, such as, for example and without limitation, pregnancy, lactation or any disease state.
대표청구항▼
1. A composition for administration to a patient for supplementing a nutritional deficiency, the composition comprising: about 880 IU to about 1320 IU vitamin A, about 480 IU to about 720 IU beta carotene, about 1.3 mg to about 1.9 mg vitamin B1, about 1.5 mg to about 2.2 mg vitamin B2, about 12 mg
1. A composition for administration to a patient for supplementing a nutritional deficiency, the composition comprising: about 880 IU to about 1320 IU vitamin A, about 480 IU to about 720 IU beta carotene, about 1.3 mg to about 1.9 mg vitamin B1, about 1.5 mg to about 2.2 mg vitamin B2, about 12 mg to about 18 mg vitamin B3, about 2 mg to about 3 mg vitamin B6, about 800 μg to about 1200 μg vitamin B9, about 4 μg to about 6 μg vitamin B12, about 48 mg to about 72 mg vitamin C, about 320 IU to about 480 IU vitamin D3, about 24 IU to about 36 IU vitamin E, about 23 mg to about 35 mg iron, about 20 mg to about 30 mg magnesium, about 12 mg to about 18 mg zinc, and one or more pharmaceutically acceptable carriers. 2. The composition of claim 1, wherein said composition is substantially free of other added vitamins and minerals. 3. The composition of claim 1, wherein the composition is administered in one or more tablets or capsules. 4. The composition of claim 1, wherein the composition is sugar coated or enteric coated. 5. The composition of claim 1, wherein said vitamin A is in the form of acetate. 6. The composition of claim 1, wherein said vitamin B1 is in the form of thiamine mononitrate. 7. The composition of claim 1, wherein said vitamin B2 is in the form of riboflavin. 8. The composition of claim 1, wherein said vitamin B3 comprises an equivalent molar amount of niacin. 9. The composition of claim 1, wherein said vitamin B6 is in the form of pyridoxine hydrochloride. 10. The composition of claim 1, wherein said vitamin B9 is in the form of folacin. 11. The composition of claim 1, wherein said vitamin B9 is in the form of metafolin. 12. The composition of claim 1, wherein said vitamin B9 is in the form of folate. 13. The composition of claim 1, wherein said vitamin B9 is in the form of folic acid. 14. The composition of claim 1, wherein said vitamin B9 is in the form of one or more natural isomers of folate. 15. The composition of claim 1, wherein said vitamin B12 is in the form of cyanocobalamin. 16. The composition of claim 1, wherein vitamin B1 is in the form of thiamine mononitrate, wherein said vitamin B2 is in the form of riboflavin, wherein said vitamin B3 is in the form of niacinamide, wherein said vitamin B6 is in the form of pyridoxine hydrochloride, wherein said vitamin B9 is in the form of folic acid, and wherein said vitamin B12 is in the form of cyanocobalamin. 17. The composition of claim 1, wherein said vitamin B9 comprises one or more natural isomers of folate consisting of (6S)-tetrahydrofolic acid or a polyglutamyl derivative thereof, 5-methyl-(6S)-tetrahydrofolic acid or a polyglutamyl derivative thereof, 5-formyl-(6S)-tetrahydrofolic acid or a polyglutamyl derivative thereof, 10-formyl-(6R)-tetrahydrofolic acid or a polyglutamyl derivative thereof, 5,10-methylene-(6R)tetrahydrofolic acid or a polyglutamyl derivative thereof, 5,10-methenyl-(6R)-tetrahydrofolic acid or a polyglutamyl derivative thereof and 5-formimino-(6S)-tetrahydrofolic acid or a polyglutamyl derivative thereof. 18. The composition of claim 1, wherein said vitamin C is in the form of ascorbic acid. 19. The composition of claim 1, wherein said vitamin D3 is in the form of cholecalciferol. 20. The composition of claim 1, wherein said vitamin E is in the form of d-alpha tocopheryl acetate. 21. The composition of claim 1, wherein said vitamin E is in the form of d-alpha tocopheryl succinate. 22. The composition of claim 1, wherein said iron is in the form of ferrous fumarate. 23. The composition of claim 1, wherein said iron is in the form of polysaccharide iron complex. 24. The composition of claim 1, wherein said magnesium is in the form of magnesium oxide. 25. The composition of claim 1, wherein said zinc is in the form of zinc oxide. 26. The composition of claim 1, wherein said one or more pharmaceutically acceptable carriers are selected from one or more of the group consisting of binders, diluents, lubricants, glidants, colorants, emulsifiers, disintegrants, starches, water, oils, alcohols, preservatives, sweetening agents, flavorants, and sugars. 27. The composition of claim 26, wherein said sweetening agent is selected from one or more of the group consisting of sucrose, fructose, high fructose corn syrup, dextrose, saccharin sodium, maltodextrin, aspartame, potassium acesulfame, neohesperidin dihydrochalcone, sucralose, monoammonium glycyrrhizinate, and mixtures thereof. 28. The composition of claim 26, wherein said flavorant is selected from one or more of the group consisting of a natural flavor oil, a synthetic flavor oil, a citrus oil, a fruit essence, an extract from a plant, an extract from a leaf, an extract from a flower, an extract from a fruit, a synthetic flavor, anise oil, cinnamon oil, peppermint oil, oil of wintergreen, clove oil, bay oil, anise oil, eucalyptus oil, thyme oil, cedar leave oil, oil of nutmeg, oil of sage, oil of bitter almonds, cassia oil, lemon oil, orange oil, lime oil, grapefruit oil, grape oil, apple essence, pear essence, peach essence, berry essence, wildberry essence, date essence, blueberry essence, kiwi essence, strawberry essence, raspberry essence, cherry essence, plum essence, pineapple essence, apricot essence, natural mixed berry flavor, citric acid, malic acid, vanilla, vanillin, cocoa, chocolate, menthol, and combinations thereof. 29. The composition of claim 1, wherein said composition further comprises alkyl polysiloxane in an amount of about 0.05 weight percent to less than about one weight percent of the composition. 30. The composition of claim 29, wherein said alkyl polysiloxane is in the form of dimethyl polysiloxane. 31. The composition of claim 1, wherein said one or more pharmaceutically-acceptable carriers comprise fructose, stearic acid, natural mixed berry flavor, croscarmellose sodium, citric acid, magnesium stearate, silicon dioxide, and malic acid. 32. A composition for administration to a patient for supplementing a nutritional deficiency, the composition comprising: about 990 IU to about 1210 IU vitamin A; about 540 IU to about 660 IU beta carotene; about 1.5 mg to about 1.75 mg vitamin B1; about 1.6 mg to about 2 mg vitamin B2; about 13.5 mg to about 16.5 mg vitamin B3; about 2.3 mg to about 2.8 mg vitamin B6; about 900 μg to about 1100 μg vitamin B9; about 4.5 μg to about 5.5 μg vitamin B12; about 54 mg to about 66 mg vitamin C; about 360 IU to about 440 IU vitamin D3; about 27 IU to about 33 IU vitamin E; about 26 mg to about 32 mg iron; about 22.5 mg to about 27.5 mg magnesium; about 13.5 mg to about 16.5 mg zinc, and one or more pharmaceutically acceptable carriers. 33. The composition of claim 32, wherein said patient is pregnant. 34. The composition of claim 32, wherein said patient is lactating. 35. The composition of claim 32, wherein said nutritional deficiency is a result of pregnancy. 36. The composition of claim 32, wherein said nutritional deficiency is a result of lactation. 37. The composition of claim 32, wherein said nutritional deficiency is a result of elevated metabolic demand. 38. The composition of claim 32, wherein said nutritional deficiency is a result of increased plasma volume. 39. The composition of claim 32, wherein said nutritional deficiency is a result of decreased concentrations of nutrient-binding proteins. 40. The composition of claim 39, wherein said nutrient-binding proteins comprise one or more proteins selected from one or more of the group consisting of serum-ferritin, maltose-binding protein, lactoferrin, calmodulin, tocopheryl binding protein, riboflavin binding protein, retinal binding protein, transthyretin, high density lipoprotein-apolipoprotein Al, folic acid binding protein, and 25-hydroxyvitamin D binding protein. 41. The composition of claim 32, wherein the one or more pharmaceutically-acceptable carriers are one or more selected from one or more of the group consisting of: binders, diluents, lubricants, glidants, colorants, emulsifiers, disintegrants; wherein the binders are selected from one or more of the group consisting of: acacia, compressible sugar, gelatin, sucrose and its derivatives, maltodextrin, cellulosic polymers, ethylcellulose, hydroxypropylcellulose, hydroxypropylmethyl cellulose, carboxymethylcellulose sodium, methylcellulose, acrylic polymers, insoluble acrylate ammoniomethacrylate copolymer, polyacrylate or polymethacrylic copolymer, povidones, copovidones, polyvinylalcohols, alginic acid, sodium alginate, starch, pregelatinized starch, guar gum, and polyethylene glycol;wherein the diluents are selected from one or more of the group consisting of: microcrystalline cellulose, sucrose, dicalcium phosphate, starches, lactose and polyols of less than 13 carbon atoms, and pharmaceutically acceptable amino acids and their mixtures;wherein the lubricants are selected from one or more of the group consisting of: stearic acid, calcium stearate, magnesium stearate, zinc stearate, talc, mineral and vegetable oils, benzoic acid, poly(ethylene glycol), glyceryl behenate, and stearyl fumarate; andwherein the glidants are selected from one or more of the group consisting of: silicon dioxide, colloidal or fumed silica, magnesium stearate, calcium stearate, stearic acid, cornstarch, and talc; andwherein the emulsifiers are selected from one or more of the group consisting of: glycerin fatty acid ester, sorbitan monostearate, sucrose fatty acid ester, lecithin and mixtures thereof; andwherein the disintegrants are selected from one or more of the group consisting of: starches, modified starches, cellulosic agents, Ac-di-sol, montmorrilonite clays, cross-linked PVP, sweeteners, bentonite, microcrystalline cellulose, croscarmellose sodium, alginates, sodium starch glycolate, gums, agar, guar, locust bean, karaya, pectin, Arabic, xanthan and tragacanth, silica with a high affinity for aqueous solvents, colloidal silica, precipitated silica, maltodextrins, beta-cyclodextrins, polymers, carbopol, cellulosic agents, hydroxymethylcellulose, hydroxypropylcellulose and hydroxyopropylmethylcellulose. 42. The composition of claim 32, wherein the composition is provided in one or a plurality of unit dose form(s) and wherein the unit dose form(s) is individually wrapped, packaged as multiple units on paper strips, packaged in a vial, packaged in blister packs, and packaged in bottles. 43. The composition of claim 32, further comprising one or more inactive ingredients. 44. The composition of claim 43, wherein said inactive ingredients are selected from one or more of the group consisting of fructose, stearic acid, natural berry mixed flavor, croscarmellose sodium, citric acid, magnesium stearate, silicon dioxide, and malic acid. 45. A composition for administration to a patient for supplementing a nutritional deficiency, the composition comprising: about 1100 IU vitamin A; about 600 IU beta carotene; about 1.6 mg vitamin B1; about 1.8 mg vitamin B2; about 15 mg vitamin B3; about 2.5 mg vitamin B6; about 1000 μg vitamin B9; about 5 μg vitamin B12; about 60 mg vitamin C; about 400 IU vitamin D3; about 30 IU vitamin E; about 29 mg iron; about 25 mg magnesium; about 15 mg zinc, and one or more pharmaceutically acceptable carriers.
Ashmead Harvey H. (Kaysville UT) Ashmead H. Dewayne (Fruit Heights UT) Graff Darrell J. (Ogden UT), Amino acid chelated compositions for delivery to specific biological tissue sites.
Allen Robert H. (Englewood CO) Stabler Sally P. (Denver CO) Lindenbaum John (New York NY), Assay for sulfhydryl amino acids and methods for detecting and distinguishing cobalamin and folic acid deficency.
Allen Robert H. (Englewood CO) Stabler Sally P. (Denver CO), Assays for sulfhydryl amino acids and methylmalonic acid and their application to diagnosis of cobalamin deficiency.
Bailey, Richard B.; DiMasi, Don; Hansen, Jon M.; Mirrasoul, Peter J.; Ruecker, Craig M.; Veeder, III, George T.; Kaneko, Tatsuo; Barclay, William R., Enhanced production of lipids containing polyenoic fatty acid by very high density cultures of eukaryotic microbes in fermentors.
Manning, Paul B.; Schramm, Jack H.; McGrath, Jr., James W., Food bars containing nutritional supplements and anti-constipation and regularity maintaining-agents.
Keane ; II Michael A. (38 Port Lewes Lewes DE 19958), L-glutamine and vitamin-containing compositions effective for inducing weight loss and for weight control.
Mulchandani Rohini P. (Worthington OH) Gluvna Judith A. (Columbus OH) Knisley Tina M. (Reynoldsburg OH) Cockram David B. (Hilliard OH), Liquid nutritional product for persons receiving renal dialysis.
Allen Robert H. (Englewood CO) Stabler Sally P. (Denver CO) Lindenbaum John (New York NY), Method for screening and distinguishing between cobalamin and folic acid deficiency based on assay for cystathionine and.
Briggs Ronald S. (Lebanon NJ) Braun Richard (Colts Neck NJ) Chen Stephen (East Brunswick NJ), Multi vitamin and mineral dietary supplement with controlled release bioavailable iron.
Paradissis George (St. Louis MO) Levinson R. Saul (Chesterfield MO) Heeter Gary (Chesterfield MO) Cuca Robert (Edwardsville IL) Kirschner Mitchell I. (St. Louis MO), Multi-vitamin and mineral supplement for pregnant women.
Uiterwaal Dirk J. D. (Bodegraven NLX) Hersevoort Aart (Nieuwegein NLX), Nutritional supplement preparation intended for pregnant and breast-feeding women based on milk constituents as well as.
Kyle David J. (Catonsville MD) Reeb Sue E. (Baltimore MD) Sicotte Valerie J. (Baltimore MD), Pharmaceutical composition and dietary supplement containing docosarexaenoic acid obtained from dinoflagellates.
Fuisz Richard C. ; Cherukuri Subraman R. ; Kota Suresh B. ; Stewart James L., Process for forming chewable quickly dispersing multi-vitamin preparation and product therefrom.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.